BLOG:
BLOG: TRIFECTA
THREE KEY TAKEAWAYS FROM BLOG:
1.) We onboard more-and-more titles, and continue to sign-up program suppliers and "MyFlix Exclusives."
2) Obviously, each major supplier - and each major Exclusive - deserves more than a passing listing in a Sunday night blog. Their PR showcase announcements will come.
3.) Understanding the dynamics and timing of the circumstances affecting the company - and implementing a strategy to circumvent such obstacles - is the formula to achieve maximum success. We are on this cusp....
HHSE INVESTOR RELATIONS
Sunday, January 31, 2021
FORWARD MOMENTUM: MYFLIX, PRODUCTIONS, FILINGS & MORE
Greetings HHSE Friends & Followers - as requested by a few key shareholders, we're taking a pause tonight from the MyFlix construction just to say "hi" and to update our progress. It's been near 24/7 the past few weeks as we onboard more-and-more titles, and continue to sign-up program suppliers and "MyFlix Exclusives." While our primary moniker as a One-Stop-Entertainment-SuperStore will still apply... it's nice to know that quite a few titles will be MyFlix Exclusives... which has been a big part of the draw for subscribers onto Netflix and Amazon Prime. Obviously, each major supplier - and each major Exclusive - deserves more than a passing listing in a Sunday night blog. Their PR showcase announcements will come. But it's still nice to backlog such a quantity of news and activities, to fuel the HHSE enthusiasm post F10 filing, post MyFlix launch and post S1 raising.
We were pleased to see that "The Vanished" (starring ANNE HECHE and THOMAS JANE) is holding solid in the TOP TEN at Netflix going into its third week of release.
Regarding HHSE Financials, our 12-31-19 filings will be modified (yet again) to conform to decisions made with respect to the 12-31-20 numbers (not yet released), as well as to reflect the cash-basis reporting of the company's corporate / consolidated tax returns. This is an inconsequential item with respect to the actual publication of the Form 10, which is delayed almost entirely due to MyFlix issues of disclosure and launch. We feel it's essential that each of the elements of our forward actions occur in a very specific order and time-frame for the maximum benefit to shareholders and to the success of the S1 raising.
We realize that many shareholders have been waiting patiently for weeks, months, YEARS for our final F10 filing, and we appreciate the impatience and general frustration. But as has been proven recently with stocks such as Sycamore Entertainment and GameStop - understanding the dynamics and timing of the circumstances affecting the company - and implementing a strategy to circumvent such obstacles - is the formula to achieve maximum success. We are on this cusp....
( 2 DIFFERENT PHOTOS "WILDFIRE" )
https://hannoverhousemovies.blogspot.com/2021...tions.html
Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigation Into SecureWorks Corp. Shareholder Fairness In recent developments, Ademi LLP has initiated an investigation into SecureWorks Corp. (NASDAQ: SCWX) concerning possible breaches of fiduciary duty related to its upcoming transaction with Sophos. This investigation raises important questions about whether SecureWorks is providing fair value to its public...
Continue Reading
VIAVI Partners with Telefónica HISPAM for Enhanced Network Management Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) recently secured a strategic agreement to provide advanced automated network inventory management for Telefónica Hispanoamérica (HISPAM). This collaboration aims to leverage Viavi's innovative NITRO AIOps solution to improve network operations throughout...
Continue Reading
Crédit Agricole Assurances Reports Remarkable Growth in 2024 Crédit Agricole Assurances recently revealed their impressive performance for the first nine months of 2024, showcasing an 18.2% increase in total revenue, amounting to €32.8 billion. This significant growth reflects the company's dedication to its clients and the effectiveness of its diverse insurance...
Continue Reading
Teads Holding Co. Engages Investors in Upcoming Conferences Teads Holding Co. (NASDAQ: TEAD), recognized as a leader in the advertising technology space, is gearing up for significant investor conferences this September. As the company continues to expand its influence and reach, it will showcase its innovative approach to marketing solutions at these events, emphasizing...
Continue Reading
Overview of the Intelligent Vending Machines Market The Intelligent Vending Machines market is undergoing rapid transformation, capturing the interest of both investors and consumers alike. As technology progresses at an astonishing pace, these machines are evolving from simple snack dispensers into advanced retail solutions. Currently valued at USD 22.15 billion, the...
Continue Reading